Screener
Jade Biosciences JBIO Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Change in fair value of Convertible Notes payable(3) | — | (15,400) |
| Other expense | (9) | — |
| Total other income (expense), net | 3,093 | (14,785) |
| Net loss before income tax expense | (40,352) | (38,169) |
| Income tax expense | (16) | — |
| Net loss | $(40,368) | $(38,169) |
| Other comprehensive income (loss): | ||
| Currency translation adjustment | 2 | — |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's pre-tax income?
- Jade Biosciences (JBIO) reported pre-tax income of -$40.35M in Q1 2026.
- How has Jade Biosciences's pre-tax income changed year-over-year?
- Jade Biosciences's pre-tax income decreased by 5.7% year-over-year, from -$38.17M to -$40.35M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Jade Biosciences's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude